Horizon Sciences & Technologies inc.

Horizon Sciences & Technologies inc.

August 28, 2007 15:47 ET

Arthrovision Inc., a Wholly-Owned Subsidiary of Horizon Sciences & Technologies Files Patent Infringement Action Against Chondrometrics GmbH and its CEO Dr. Felix Eckstein

MONTREAL, QUEBEC--(Marketwire - Aug. 28, 2007) - ArthroVision Inc., a wholly-owned subsidiary of Horizon Sciences & Technologies Inc. has filed a patent infringement complaint before the District Court of Munich, Germany, accusing Chondrometrics of infringing the German part of ArthroVision's European patent (EP) 1 230 561 B1. The patent protects a system and method for evaluating disease progression using magnetic resonance imaging. In the complaint, ArthroVision alleges inter alia that Chondrometrics' software "Chondrometrics_work", designed to segment and evaluate magnetic resonance images, makes use of claim 11 and contributes to infringe claim 1 of ArthroVision's patent.

The invention of EP 1 230 561 B1 can in particular be used for pursuing the course of osteoarthritis of a patient when the respective patient is treated with a certain drug. Claim 1 and 11 of EP 1 230 561 B1 relate to a system and method by which magnetic resonance imaging data is obtained, e.g. of an anatomical object such as a joint. These data are then transformed into three dimensional data. A comparison module eventually compares the so transformed images which are being generated successively. By this process, quantitative differences of the anatomic object can be detected. The invention can therefore be used to evaluate differences for example in the cartilage thickness and volume over a certain period of time, and eventually enable to keep track of the evolution of the cartilage of the diseased joint.

The complaint, serves to protect ArthroVision's intellectual property since ArthroVision is committed to continue to develop innovative tools for the evaluation and the measurement of cartilage changes. ArthroVision believes to be the first to having developed an MRI system capable of making reliable quantitative measurements of cartilage loss attributable to disease in human and veterinary patients.

Facts about Horizon Sciences & Technologies Inc. and its subsidiary ArthroVision Inc.:

Horizon Sciences & Technologies Inc. is a Canadian biopharmaceutical company, located in Montreal (Quebec) which has the role of discovering and of developing, in collaboration with its partners, new drugs and innovative technologies in the field of the prevention, the diagnosis and the treatment of osteoarthritis. Its subsidiary, ArthroVision Inc., a Montreal, Quebec, Canada based company, is engaged in the research and development of imaging technology to assess the effect of therapeutics in the treatment of osteoarthritis. ArthroVision has developed a system that allows the precise measurement of cartilage thickness and volume from magnetic resonance images (MRIs) and the tracking of cartilage degradation over time. This technology is unique and represents a breakthrough for osteoarthritis research. ArthroVision has expertise in conducting clinical trials for the assessment of the efficacy of new drug compounds that aim at reducing the progression of osteoarthritis.

Contact Information

  • Horizon Sciences & Technologies inc.
    Bertrand Masse, CA
    Chief Financial Officer
    514-890-8000 ext. 28915